Switch to:
More From Other Websites
8:02 am aTyr Pharma: FDA grants Fast Track Designation for aTyr's Resolaris to treat limb girdle... Jan 18 2017
FDA Grants Fast Track Designation for aTyr's Resolaris™ to Treat Limb Girdle Muscular Dystrophy 2B... Jan 18 2017
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure Jan 09 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Atyr Pharma Inc (LIFE) CEO and Director John Mendlein Bought $151,800 of Shares Dec 21 2016
Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers? Dec 16 2016
aTyr Pharma downgraded by JP Morgan Dec 13 2016
aTyr Pharma Drops on Clinical Update Dec 13 2016
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events Dec 13 2016
aTyr Pharma Reports Promising Signals of Clinical Activity in Multiple Rare Genetically Distinct... Dec 13 2016
aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference Dec 09 2016
aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 5, 2016 Dec 05 2016
ATYR PHARMA INC Financials Nov 23 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
ATYR PHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Nov 21 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
aTyr Pharma (LIFE) Looks Good: Stock Adds 5.9% in Session Nov 18 2016
aTyr Pharma Announces Third Quarter 2016 Operating Results Nov 14 2016
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 14 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK